D-Wave Quantum convenes the inaugural Qubits Japan 2025 user conference in Tokyo to advance annealing quantum computing adoption across the Asia–Pacific region. Featuring senior executives and research leaders, the event highlights real-world applications in AI, machine learning, network optimization, and quantum-assisted drug discovery pilots with major partners.
Key points
- Qubits Japan 2025 spotlights D-Wave’s annealing QPU deployments with sub-second response times, on-premises and cloud.
- APAC partnerships include Japan Tobacco pharma pilot for quantum AI drug discovery and NTT DOCOMO network optimization reducing base-station congestion by 15%.
- Strategic MOU with Yonsei University aims to install an Advantage2 system in Incheon for biotech and materials science research.
Why it matters: By convening regional experts and showcasing practical quantum applications, Qubits Japan 2025 accelerates AI-driven optimization and drug discovery innovations across industries.
Q&A
- What is quantum annealing?
- How does a QPU differ from a gate-model quantum computer?
- Why is quantum computing useful for drug discovery?
- What advantages does D-Wave’s Advantage2 system offer?
